Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Eur Child Adolesc Psychiatry ; 26(5): 603-617, 2017 May.
Article in English | MEDLINE | ID: mdl-27942998

ABSTRACT

Our objectives were to assess health-related quality of life (HRQoL), anxiety, depression of Gilles de la Tourette syndrome (GTS) adolescents' parents compared to controls; to assess GTS adolescents' HRQoL compared to controls; to investigate which parental and adolescent variables are associated with poorer parental HRQoL. The controlled study involved GTS outpatients and their parents, adolescent healthy controls matched for gender and age and their parents. Parents' HRQoL was assessed using SF-36 and WHOQOL-BREF; anxiety, depression using HADS. Adolescents' HRQoL was assessed by adolescents using VSP-A instrument and by their parents using VSP-P. A total of 75 GTS adolescents, 75 mothers, 63 fathers were compared to 75 control adolescents, 75 mothers, 62 fathers. GTS mothers had worse HRQoL than controls on 5 of the 8 SF-36 dimensions and 1 of the 4 WHOQOL-BREF dimensions, while GTS fathers had worse HRQoL on 2 of the WHOQOL-BREF dimensions. GTS mothers had poorer HRQoL than fathers. GTS mothers had more depression than control mothers and GTS fathers had more anxiety than control fathers. GTS adolescents had worse HRQoL than controls on 5 of the 9 VSP-A dimensions. Factors significantly related to parental HRQoL were anxiety, depression, GTS adolescents' HRQoL and, concerning mothers, behavioural and emotional adolescents' problems; concerning fathers, severity of vocal tics, duration since first symptoms. This study provides a better understanding of poorer HRQoL and psychiatric morbidity of GTS adolescents' parents. Clinicians should pay attention to their emotional well-being and HRQoL and be aware that mothers and fathers are differently affected.


Subject(s)
Anxiety/psychology , Depression/psychology , Parents/psychology , Quality of Life/psychology , Tourette Syndrome/diagnosis , Adolescent , Adult , Anxiety/epidemiology , Case-Control Studies , Depression/epidemiology , Female , Health Status , Humans , Male , Mental Health , Middle Aged , Outcome Assessment, Health Care , Psychiatric Status Rating Scales , Surveys and Questionnaires , Tics/psychology , Tourette Syndrome/psychology
2.
Neurochirurgie ; 52(1): 15-25, 2006 Feb.
Article in French | MEDLINE | ID: mdl-16609656

ABSTRACT

The subthalamic nucleus (STN) is the main target of deep brain stimulation (DBS) treatment for severe idiopathic Parkinson's disease. But there is still no clear information on the location of the effective contacts (used during the chronic phase of stimulation). Our aim was to assess the anatomical structures of the subthalamic area (STA) involved during chronic DBS. Ten patients successfully treated were included. The surgical procedure was based on direct STN targeting (stereotactic MRI based) pondered by the acute effects of intraoperative stimulation. We used a formaldehyde-fixed human specimen to compare by matching MRI images obtained at 1.5 Tesla (performed in clinical stereotactic conditions) and at very high field at 4.7 Tesla. This allowed accurate analysis of the anatomy of the STA and retrospective precision of the location of the center of effective contacts which were located within the STN in 4 patients, at the interface between the STN and the ZI and/or FF in 13, at the interface between ZI and FF in 2 and between the STN and the substantia nigra in one. These results were consistent with the literature, revealing the implication of neighboring structures, especially the zona incerta and Forel's Field, in the clinical benefit.


Subject(s)
Deep Brain Stimulation , Electrodes, Implanted , Magnetic Resonance Imaging , Parkinson Disease/therapy , Stereotaxic Techniques , Subthalamic Nucleus/pathology , Aged , Female , Humans , Male , Middle Aged , Neurologic Examination , Parkinson Disease/pathology , Parkinson Disease/physiopathology , Substantia Nigra/pathology , Substantia Nigra/physiopathology , Subthalamic Nucleus/physiopathology , Subthalamus/pathology , Subthalamus/physiopathology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...